HC Wainwright & Co. Initiates Coverage On 89bio with Buy Rating, Announces Price Target of $46
HC Wainwright & Co. analyst Ed Arce initiates coverage on 89bio (NASDAQ:ETNB) with a Buy rating and announces Price Target of $46.
89bio Highlights Presentation Of New Sub-Analysis From Phase 1b/2a NASH Study Of BIO89-100 At American Association for the Study of Liver Diseases Nov. 14
89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced
RBC Capital Maintains Outperform on 89bio, Lowers Price Target to $46
RBC Capital analyst Brian Abrahams maintains 89bio (NASDAQ:ETNB) with a Outperform and lowers the price target from $48 to $46.
Raymond James Maintains Outperform on 89bio, Lowers Price Target to $33
Raymond James analyst Steven Seedhouse maintains 89bio (NASDAQ:ETNB) with a Outperform and lowers the price target from $35 to $33.
89bio Q2 EPS $(1.03) Down From $(0.85) YoY
89bio (NASDAQ:ETNB) reported quarterly losses of $(1.03) per share. This is a 21.18 percent decrease over losses of $(0.85) per share from the same period last year.
89bio Says Completed Target Enrollment In Histology Cohort To Evaluate BIO89-100 For Treatment Of NASH
89bio, Inc. (NASDAQ:ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam’s Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 15)
Stocks That Hit 52-Week Lows On Thursday
During the morning session on Thursday, 152 stocks hit new 52-week lows.